In a significant breakthrough for oncology and molecular biology, a multidisciplinary team of investigators at the Johns Hopkins Kimmel Cancer…
Read More
Immunai and Boehringer Ingelheim Forge Strategic Alliance to Uncover Novel T-Cell Targets in Oncology and Autoimmune Diseases
Immunai, a leading artificial intelligence (AI) company specializing in immune system analysis, and Boehringer Ingelheim, a global biopharmaceutical giant, have…
Read More
Novartis and Antares Therapeutics Forge Landmark Oncology Collaboration to Tackle Undruggable Cancer Targets
In a significant move poised to accelerate the development of novel cancer therapies, Novartis has entered into a strategic collaboration…
Read More
Precision DNA Editing Targets Root Cause of Severe Childhood Epilepsy in Preclinical Study
A groundbreaking preclinical study led by researchers at The Jackson Laboratory (JAX; ME, USA) has successfully utilized precision gene editing…
Read More
Precision DNA editing targets root cause of severe childhood epilepsy in a preclinical study.
In a landmark preclinical study, researchers from The Jackson Laboratory (JAX; Bar Harbor, ME, USA), in collaboration with the Broad…
Read More
Breakthrough Combination Therapy Targets Cellular Differentiation Blocks to Provide New Treatment Pathway for Acute Myelogenous Leukemia
In a significant advancement for hematological oncology, researchers from Ludwig Cancer Research have unveiled a novel therapeutic strategy aimed at…
Read More
Innovative Gene Therapy Targets Chronic Pain Circuits Without Addiction Risk in Landmark Preclinical Study
In a significant advancement for neurobiology and pain management, researchers from the University of Pennsylvania, Stanford University, and Carnegie Mellon…
Read More
The World Health Organization Targets Urgent Antibiotic Development to Combat Evolving Drug Resistance
The World Health Organization (WHO) has taken a significant step in its ongoing battle against antimicrobial resistance (AMR) by publishing…
Read MoreYOU MAY HAVE MISSED
